OneSkin

Nuritas claims world’s first AI-discovered anti-inflammatory

Latest articles

Exclusive video interview with Erin Sharoni of JUVICELL

We talk fasting, lifespan and longevity supplements with JUVICELL's co-founder, Erin Sharoni. Recently, we were excited to cover the launch of brand-new longevity supplement JUVICELL,...

Longevity supplement innovator soft-closes $5.5m

Ponce de Leon: the longevity supplement company behind Rejuvant could raise up to $15m in current series B round. Ponce de Leon Health, a company...

Swiss longevity company builder launches

Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice. Already touted as a hotbed of longevity innovation, Switzerland is...

New aging clock is a key longevity tool

A new aging clock that's close to the theoretical limit of accuracy boasts unprecedented precision and offers new insights into how the aging process...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Apollo Neuro

Editor's picks

Exclusive video interview with Erin Sharoni of JUVICELL

We talk fasting, lifespan and longevity supplements with JUVICELL's co-founder, Erin Sharoni. Recently, we were excited to cover the launch of brand-new longevity supplement JUVICELL,...

Longevity supplement innovator soft-closes $5.5m

Ponce de Leon: the longevity supplement company behind Rejuvant could raise up to $15m in current series B round. Ponce de Leon Health, a company...

Swiss longevity company builder launches

Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice. Already touted as a hotbed of longevity innovation, Switzerland is...
OneSkin

Nuritas does it rice and easy with peer-reviewed publication revealing natural peptides that reduce inflammation.

Nuritas, a Dublin-based company that boasts U2’s Bono and The Edge among its investors, has published a paper detailing the discovery of natural rice-based peptides clinically proven to impact inflammation and improve physical test results in an elderly population.

Longevity.Technology: Nuritas is centre-stage when it comes to AI-based natural molecule discovery. The independently peer-reviewed scientific paper in Foods Journal outlines the discovery of rice-based peptides that could not only decrease harmful inflammaging, but prevent the development of lifestyle- and metabolic-related diseases.

Although the discovered peptides are found within a staple food source, their health benefit cannot be achieved by just eating rice. Instead, once Nuritas identified the peptide molecules from amongst the billions of rice peptides using AI, researchers were able to unlock their biological functionality and carry out lab-based testing and a human clinical trial. Inflammaging is a chronic low-grade inflammation that develops as we age. Thought to accelerate the process of biological aging and to worsen many age-related diseases, inflammaging is closely associated with age-related morbidity and mortality and increased risk of muscle wastage, strength loss and compromised immunity.

The peptide was identified using the proprietary AI technology NπΦ (Nuritas Peptide Finder). The clinical trial trial showed that the peptide inhibits TNF-α, an inflammatory cytokine. Reducing the amount of TNF-α in the blood corresponds with significant improvements in a number of standardised physical tests, which could be useful predictors of the likelihood of frailty-related accidents, for example.


 

“… 2020 is looking to be a seminal year in the way that consumers value and are taking responsibility for their health.”

 


 

Dr Nora Khaldi, Nuritas Founder and CEO, said: “The results of the trial couldn’t come at a more significant time. With COVID-19 heightening general awareness of inflammation and cytokines, discovering a natural product which can assist is a hugely significant finding for the team. This is as a result of years of hard work refining our AI and machine learning platform in combination with our expert in-house laboratory and team of world class scientific advisors.”

Neil Foster, head of strategic partnerships at Nuritas, added: “2020 is looking to be a seminal year in the way that consumers value and are taking responsibility for their health. Consumers are also becoming far more discerning, they want natural but also the latest science and efficacy that can be measured or better still felt.

“Against this backdrop Nuritas is launching three new products, had multiple papers published with some incredible clinical results. The interest and appetite for the Nuritas offering of fully characterised natural products that work is incredible.”

Image credit: zcf428526 / Pixabay
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
OneSkin

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...

NAD+ and metformin: AgelessRx’s anti-aging platform

Personalised longevity medicine is the top goal for AgelessRx. In November we spoke to Anar Isman, the Co-founder & CEO of AgelessRx, about PEARL, the...
Apollo Neuro

Related articles

Fall detection tech a focus for investors

EchoCare raising funds to target acute fall detection and other emergencies with privacy-sensitive, radar-based system.In the US-alone, for nonfatal falls, Medicare paid approximately $28.9...

At-home diagnostic system sees growth in older users

Tyto Care conducted more than 650,000 telehealth exams last year as COVID-19 drives increased uptake, including in senior care environments. The COVID-19 pandemic has driven...

Stimulate your brain and boost your longevity

NeoRhythm uses electromagnetic pulses to help you improve your sleep, manage pain, reduce stress and more. Slovenian start-up OmniPEMF is aiming to help people improve...

2021 hits the longevity ground running

Highlights from longevity research, trials and funding in January 2021 Hundreds of companies are working to develop treatments to slow down aging and increase healthy...

AI fast-tracks human longevity extension

Top longevity leaders frame how next-gen AI can extend lifespan. Deep Longevity, which specialises in the development and the application of next-generation AI for aging...
OneSkin